DU

DuChemBio Co, LTD

Develops, manufactures, and commercializes radiopharmaceuticals for diagnosis and treatment.

176750 | KO

Overview

Corporate Details

ISIN(s):
KR7176750008
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 81(서교동, 서봉갤러리), 서울특별시

Description

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-16 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2024-12-16 00:00
상장폐지결정 (코스닥시장 이전상장)
Korean 8.7 KB
2024-12-16 00:00
증권발행실적보고서
Korean 117.5 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-12-12 00:00
유상증자또는주식관련사채등의청약결과(자율공시)
Korean 7.5 KB
2024-12-10 00:00
[발행조건확정]증권신고서(지분증권)
Korean 161.7 KB
2024-12-10 00:00
[기재정정]투자설명서
Korean 3.8 MB
2024-12-09 00:00
유상증자최종발행가액확정 (일반공모)
Korean 4.9 KB
2024-12-09 00:00
[발행조건확정]증권신고서(지분증권)
Korean 507.5 KB
2024-12-09 00:00
[기재정정]투자설명서
Korean 4.2 MB
2024-12-09 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 118.9 KB
2024-12-05 00:00
투자설명서
Korean 3.6 MB
2024-12-04 00:00
[기재정정]증권신고서(지분증권) (2024.12)
Korean 3.7 MB
2024-11-20 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 84.1 KB
2024-11-20 00:00
[기재정정]증권신고서(지분증권) (2024.12)
Korean 4.1 MB

Automate Your Workflow. Get a real-time feed of all DuChemBio Co, LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DuChemBio Co, LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DuChemBio Co, LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.